Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Evidence released in the Lancet demonstrates a link between patient age and risk of revision on knee and hip replacements.

Researchers at NDORMS, University of Oxford have examined data from over 100,000 patients who have previously undergone joint replacements to enable prediction of the likelihood of requiring surgical revision of the joint.

There are an increasing number of patients undergoing total knee and hip joint replacements every year. These have proven beneficial to patients, but with replacement comes the risk that the joint might require subsequent surgical revision which, in turn, can lead to less favourable outcomes.

Their study has shown that while the lifetime risk of joints requiring revision is around 5% in patients who receive joint replacements at aged 70 or above, for men in their early fifties this can rise to over a third. Presenting risk information in this way can allow patients, particularly younger patients, to make more informed decisions about if and when to opt for joint replacement surgery.

Lead Investigator Professor Andrew Price, Prof of Musculoskeletal Sciences at NDORMS confirmed "This work is of great importance for all patients who are considering whether to undergo a joint replacement. It is critical that they have the best information available to make informed decisions and we believe this work is a significant contribution to achieve this goal".

To read the full paper entitled "The effect of Patient Age at Intervention on Risk of Implant Revision after Total Replacement of the Hip or Knee: A population=based cohort study" can be read here.

Similar stories

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.